We have updated the ordering process to allow all products and services to be purchased with a single PO, please address all POs to Horizon Discovery Biosciences Limited. Contact us for assistance.

Horizon's executive management team

Horizon’s leadership team have extensive experience within healthcare and life sciences 

Terry Pizzie - Chief Executive Officer

Terry Pizzie headshotTerry became Chief Executive Officer in May 2018 having joined Horizon Discovery Group in February 2017 as Head of Commercial Operations. He has amassed more than 30 years of commercial experience within the biotechnology tools sector. He started his career with Applied Biosystems in 1988 in a sales role and became Vice President of Europe in 2003. Terry went on to join the Swedish biotechnology firm Biacore in 2005 as SVP Global Commercial Operations and was part of the team that reignited the company’s commercial success, culminating in its acquisition by GE Life Sciences. After a period with Genetix PLC as Director, Global Commercial Operations prior to its acquisition by Danaher, Terry went on to head global sales at Pacific Biosciences. Terry graduated with a degree in physiology and biochemistry from the University of Reading and has spent most of his working life focused on commercial excellence within the sector.

Jayesh Pankhania - Chief Financial Officer

Jayesh Pankhania headshotJayesh was appointed Chief Financial Officer in January 2019 having joined Horizon Discovery in April 2018 as Interim Chief Financial Officer, leading the transformation of the finance function, the implementation of strong financial and corporate governance and the development of Horizon Discovery’s strategy.Prior to joining Horizon Discovery, he served as Chief Financial Officer of Xtera Limited, a provider of subsea telecoms technology, from 2017 to 2018, and HOC Group, a construction company, from 2015 to 2016. From 2011 to 2015, he was in a Deputy Chief Financial Officer role at Asia Resource Minerals plc. Jayesh is a Chartered Accountant with over 25 years’ senior finance experience. He is the founder and director of Nisaba Limited. He holds an M.B.A. from the London Business School and a degree in Accountancy from the University of East Anglia, and qualified with PricewaterhouseCoopers. Jayesh is Founder and Director of Nisaba Limited.

Kim Nichols - Head of Global Operations

Kim Nichols headshotKim joined Horizon Discovery as Head of Global Operations in September 2017, following the acquisition of Dharmacon. She is an experienced Senior Operations Director with over 17 years’ experience in product/project development within the RNA interference (RNAi), gene editing, consumables (plastics), and molecular biology and brings extensive experience in global supply chain management, manufacturing, performance and quality assurance, information technology, crossfunctional team leadership, scientific collaboration management and cost reductions through improved process performance. Prior to becoming part of Horizon Discovery’s team, She had been with the Dharmacon business for more than 18 years in various operational roles under Thermo Fisher Scientific and GE Healthcare. Kim holds a degree in genetics from Iowa State University.

Dr Chris Lowe - Head of Research Operations

Dr. Chris Lowe headshotChris was appointed Head of Research Operations in January 2017, having joined Horizon Discovery in 2011. Prior to leading all research operations within the Horizon Discovery Group, he led the scientific teams responsible for the development and provision of a range of translational research services to support preclinical drug discovery programs as RRD Director from September 2013 to January 2017. He serves on the board of directors of Avvinity Therapeutics Limited. Chris has a background in the genetic analysis of complex disease. He obtained his Ph.D. in the field of medical genetics from the University of Cambridge, where he engaged in research into the genetic causes of Type 1 diabetes in the laboratory of Prof. John Todd, and followed with postdoctoral work focusing on Type 2 diabetes and metabolic disease in the laboratory of Prof. Stephen O’Rahilly. Chris holds a bachelor’s degree in molecular biology and biotechnology from the University of Hull.

Julie Cormack - Global Head of HR

Julie Cormack headshotJulie joined Horizon Discovery as Global Head of Human Resources in July 2019. She has extensive experience helping organizations in high growth environments and is a Chartered Fellow of the Institute of Personnel Development. Prior to joining Horizon Discovery, Julie was Global Head of Human Resources at Getronics, an information technology and services company, from September 2018 to May 2019, and CPA Global Ltd., an intellectual property management and technology company, from May 2014 to September 2017. She holds a degree in Ancient History and Archaeology from the University of Birmingham and a masters in Japanese from the University of Essex.

Brian Burke - Global Head of Strategy and Corporate Development

Dr. Brian Burke headshotBrian was appointed Global Head of Strategy and Corporate Development in August 2018, having joined Horizon Discovery in August 2012 as a Global Business Development Manager. He is responsible for driving strategic development and execution across Horizon Discovery’s business. Before joining Horizon Discovery, Brian worked in a number of commercial and licensing roles with a particular focus on gene editing, bioproduction and nextgeneration sequencing. He holds a first class honours degree from the University of Glasgow and a Ph.D. from the University of Leeds.

Gabe Longoria - Head of Global Commercial

Gabe Longoria headshotGabe was appointed Head of Global Commercial in January 2019, having joined Horizon Discovery in April 2017 as Head of Strategic Alliance until December 2017 and then serving to Head of Global Sales from January 2018 until December 2018. He is responsible for leading and managing all commercial operations of the business to ensure that profitable business growth is accelerated and commercial success is achieved. Prior to joining Horizon Discovery, Gabe was Director of North America Sales of the Bioproduction and Drug Discovery Divisions, from August 2015 to April 2017, and the Biotherapeutics Division, from July 2012 to July 2015, of Molecular Devices LLC, a subsidiary of Danaher Corp. He has more than 25 years’ commercial experience in cell biology, biotherapeutics and drug discovery, encompassing various sales, marketing and product management roles. Gabe holds a degree in microbiology from the University of Arizona.

Paul Brooks - Head of Business Operations

Dr, Paul Brooks headshotPaul was appointed Head of Business Operations in November 2019. He has over 20 years of experience in leading the successful development and commercialization of tools and services for academic, pharmaceutical, biopharmaceutical and molecular diagnostic markets. Previously, he was Interim Head of Sales for Abcam plc, from January 2019 to July 2019. He has held senior leadership positions in the U.S. and the U.K., including Chief Commercial Officer and Executive Board member of Oxford Genetics Ltd; Head of Discovery Research Services at MilliporeSigma (Merck KGaA); and Global Marketing Manager at Sigma-Aldrich Corp. Paul has a BSc in Biochemistry from the University of Wales, a Ph.D. in Molecular Biology from the University of Manchester Institute of Science and Technology (UMIST), and an MBA from the University of Nottingham Business School.